v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Paid-in capital
Accumulated deficit
Beginning balance at Dec. 31, 2024 $ 8,850     $ 276,342 $ (267,492)
Beginning balance (in shares) at Dec. 31, 2024   2,545,922 351,037    
Net loss (1,429)       (1,429)
Vesting of restricted stock awards (in shares)   15,024      
Issuance of common stock - private placement, net of issuance cost 1,245     1,245  
Issuance of common stock - private placement, net of issuance cost (in share)   499,998      
Share-based compensation expense related to stock options and restricted stock awards 114     114  
Ending balance at Mar. 31, 2025 8,780     277,701 (268,921)
Ending balance (in shares) at Mar. 31, 2025   3,060,944 351,037    
Beginning balance at Dec. 31, 2024 8,850     276,342 (267,492)
Beginning balance (in shares) at Dec. 31, 2024   2,545,922 351,037    
Net loss (1,753)        
Ending balance at Jun. 30, 2025 8,570     277,815 (269,245)
Ending balance (in shares) at Jun. 30, 2025   3,075,968 351,037    
Beginning balance at Dec. 31, 2024 8,850     276,342 (267,492)
Beginning balance (in shares) at Dec. 31, 2024   2,545,922 351,037    
Ending balance at Dec. 31, 2025 $ 9,085     280,105 (271,020)
Ending balance (in shares) at Dec. 31, 2025 3,821,236 3,821,236 351,037    
Beginning balance at Mar. 31, 2025 $ 8,780     277,701 (268,921)
Beginning balance (in shares) at Mar. 31, 2025   3,060,944 351,037    
Net loss (324)       (324)
Vesting of restricted stock awards (in shares)   15,024      
Share-based compensation expense related to stock options and restricted stock awards 114     114  
Ending balance at Jun. 30, 2025 8,570     277,815 (269,245)
Ending balance (in shares) at Jun. 30, 2025   3,075,968 351,037    
Beginning balance at Dec. 31, 2025 $ 9,085     280,105 (271,020)
Beginning balance (in shares) at Dec. 31, 2025 3,821,236 3,821,236 351,037    
Net loss $ (3,177)       (3,177)
Vesting of restricted stock awards (in shares)   15,024      
Issuance of common stock - ATM 825     825  
Issuance of common stock - ATM (In Shares)   405,000      
Share-based compensation expense related to stock options and restricted stock awards 58     58  
Ending balance at Mar. 31, 2026 6,791     280,988 (274,197)
Ending balance (in shares) at Mar. 31, 2026   4,241,260 351,037    
Beginning balance at Dec. 31, 2025 $ 9,085     280,105 (271,020)
Beginning balance (in shares) at Dec. 31, 2025 3,821,236 3,821,236 351,037    
Net loss $ (4,932)        
Ending balance at Jun. 30, 2026 $ 5,087     281,039 (275,952)
Ending balance (in shares) at Jun. 30, 2026 4,256,284 4,256,284 351,037    
Beginning balance at Mar. 31, 2026 $ 6,791     280,988 (274,197)
Beginning balance (in shares) at Mar. 31, 2026   4,241,260 351,037    
Net loss (1,755)       (1,755)
Vesting of restricted stock awards (in shares)   15,024      
Share-based compensation expense related to stock options and restricted stock awards 51     51  
Ending balance at Jun. 30, 2026 $ 5,087     $ 281,039 $ (275,952)
Ending balance (in shares) at Jun. 30, 2026 4,256,284 4,256,284 351,037